Abstract: Behavioral and electrophysiological evidence indicates that the biological clock in the hypothalamic suprachiasmatic nuclei (SCN) can be reset at night through release of glutamate from the retinohypothalamic tract and subsequent activation of nitric oxide synthase (NOS). However, previous studies using NADPH-diaphorase staining or immunocytochemistry to localize NOS found either no or only a few positive cells in the SON. By monitoring conversion of L-[ 3H]arginine to L-[3H]-citrulline, this study demonstrates that extracts of SON tissue exhibit NOS specific activity comparable to that of rat cerebellum. The enzymatic reaction requires the presence of NADPH and is 0a2/calmodulin-dependent. To distinguish the neuronal isoform (nNOS; type I) from the endothelial isoform (type Ill), the enzyme activity was assayed over a range of pH values. The optimal pH for the reaction was 6.7, a characteristic value for nNOS. No difference in nNOS levels was seen between SON collected in day versus night, either by western blot or by enzyme activity measurement. Oonfocal microscopy revealed for the first time a dense plexus of cell processes stained for nNOS. These data demonstrate that neuronal fibers within the rat SON express abundant nNOS and that the level of the enzyme does not vary temporally. The distribution and quantity of nNOS support a prominent regulatory role for this nitrergic component in the SON. Key Words: Oircadian rhythms-Oonfocal microscopy-Nitric oxide synthase-Rat-Suprachiasmatic nucleus. J. Neurochem. 68, 855-861 (1997).
ioral phase adjustments (Ding et a!., 1994; Shirakawa and Moore, 1994) . Both light and glutamate are effective at phase resetting only at night.
The signaling pathway activated in the SCN by glutamate involves NO. NOS inhibitors or NO donors blocked and mimicked glutamate-induced phase shifts, respectively, in the SCN brain slice (Ding et a!., 1994; Watanabe et al., 1994) . When the NOS inhibitor Nnitro-L-arginine methyl ester (L-NAME) was injected into the SCN region of hamsters, light-induced shifts in the phase of wheel-running rhythms were effectively blocked (Watanabe et a!., 1995; Weber et al., 1995) . L-Arginine, a natural substrate of NOS, outcompeted the inhibitory effect of L-NAME both in vivo and in vitro (Ding et a!., 1994; Weber et al., 1995) . Also, the SCN is sensitive to NO only during the night phase of the clock (Ding et a!., 1994; see, however, Starkey, 1996) .
Despite this compelling functional evidence, demonstration of NOS in the SCN has been elusive. The SCN was not among the positive areas reported by studies mapping NOS throughout the rat brain using either immunocytochemistry (ICC) or NADPHdependent diaphorase (NADPH-d) histochemistry (Bredt et a!., 1991; Vincent and Kimura, 1992) . Nevertheless, significant NOS specific activity has been measured in extracts of SCN at nighttime (Ding et a!., 1994) . To resolve this apparent paradox, we sought to identify and characterize the isoform( s) of the NOS expressed in the SCN and to localize the putative NOsynthesizing components by ICC.
MATERIALS AND METHODS

Brain slice preparation and tissue collection
Inbred Long-Evans rats were born and raised in our colony for 6-9 weeks. The animals were allowed free access to rat chow and water and maintained at the desired 12-h light! 12-h dark lighting schedule for at least 2 weeks before they were killed. The procedures for brain slice preparation and tissue collection have been described previously (Prosser and Gillette, 1991) . In brief, coronal hypothalamic slices (500 1iM) containing the SCN were either frozen immediately or maintained at the gas-media interface of a brain slice chamber for at least 4 h before tissue collection at the desired circadian time (CT). CT is reckoned from CT 0, "lights on" in the rat colony, and continues for 24 h. Slices were transferred to a dry ice-cooled glass slide, and the SCN was punched out with a flattened 28-gauge syringe needle under a dissecting microscope. Punches were kept at -70°C until use, for up to 1 week. Tissue punches of cerebellar and hippocampal slices were collected in the same way except that they were frozen immediately after removal from the brain.
NOS activity measurement NOS activity was assayed by monitoring the conversion of radiolabeled arginine to citrulline (Bredt and Snyder, 1990) . Tissue was disrupted by five freeze-thaw cycles, placed in 50 mM HEPES buffer (pH 7.1) containing 1 mM dithiothreito! and 1 mM EDTA, and then centrifuged at 10,000 g for 5 mm. The supernatant was passed through a Dowex 50 (Nat form; Sigma) column to remove endogenous arginine before 0.12~.tML-[ 3H]arginine (36.7 iiCi/iil; Du Pont) and 0.3 ,uM L-arginine were added. The reaction was initiated by addition of 0.5 mM /3-NADPH, 10~tglml calmodulin, and 1.25 mM CaC1 2 in a total volume of 100~tlcontaining -~20~sgof protein. After incubation at 22°Cfor 10 mm, the reaction was stopped by adding ice-cold HEPES buffer (pH 5.5, 4 mM EDTA), and reactants were separated on another Dowex 50 column, eluted, and counted for radioactivity. The identity of [ 3H] citrulline was confirmed by paper chromatography. The quantitative recovery of citrulline was determined using L-['4C] citrulline. Protein concentrations were measured by the assay of Bradford (1976) .
Western analysis of NOS
Punches of SCN at CT 7 and 14 and cerebellum were prepared as described above. Membrane-bound, soluble, and total protein extracts were prepared immediately before electrophoresis.
Total protein extract. Two punches (~10~tg of protein) of each sample were suspended in 40~l ofdenaturing buffer, sonicated briefly, and boiled for 3 mm.
Membrane-bound and soluble protein extracts. For each sample, two punches were resuspended in 20~ilof fractionation buffer [20mM HEPES (pH 7.2), 0.2 mM EDTA, 1.0 mM EGTA, 1.0 mM NaF, 5 ,aM microcystin, 0.5~zg/ml leupeptin, 0.7 ,ug/ml pepstatin, 1.0~ig!ml aprotinin, 40 gig! ml bestatin, 10 mM glycerol phosphate, 5 mM dithiothreitol, and 0.5 mM phenylmethylsulfonyl fluoride] and centrifuged at 100,000 g (60 mm, 4°C).After centrifugation, both the supematant (soluble protein) and precipitate (membranebound protein) were diluted to final volumes of 40~il in denaturing buffer and boiled for 3 mm. Thirty-five microliters ofeach sample was subjected to sodium dodecyl sulfatepolyacrylamide gel electrophoresis on a 7.5% gel and transferred to nitrocellulose (pore size, 0.2 j~sm;Bio-Rad). The remaining 5~l of each sample was subjected to silver staining to evaluate protein loading.
Nitrocellulose blots were probed with the following monoclonal anti-peptide antibodies (Transduction Labs): rabbit anti-nNOS, rabbit anti-eNOS, rabbit anti-iNOS, mouse anti-nNOS, mouse anti-eNOS, and mouse anti-iNOS. A rabbit polyclonal antibody against the entire nNOS protein (1:1,000) was also tested (Kummer et al., 1992) . Immunoreactivity was visualized using horseradish peroxidase-linked goat anti-rabbit (Chemicon) or goat anti-mouse (Zymed) secondary antibody and an ECL fluorescence detection system (Amersham). Specificity of immunoreactive bands was determined by preabsorbing the polyclonal nNOS antibody with 25 [Lg/ml nNOS purified from baculovirus-infected insect cells (Harteneck et al., 1994) for 60 mm atroom temperature before probing nitrocellulose blots.
ICC and confocal microscopy
Four animals were anesthetized with sodium pentobarbital (75 mg!kg i.p.) and perfused intracardially with chilled 0.1 M phosphate-buffered saline (pH 7.4) followed by chilled 4% paraformaldehyde in phosphate-buffered saline. The brains were removed, postfixed, and sectioned at 50-80~im by a Vibratome. Tissue sections were incubated with 0.3% Triton X-100 detergent and 5% heat-inactivated goat serum to permeabilize the membrane and to block nonspecific binding sites, respectively. The sections were next incubated with the rabbit polyclonal anti-nNOS antibody (Kummer et al., 1992 ). Altemate sections were tested with preabsorbed antibody as described earlier and processed for the fluorescein isothiocyanate-conjugated avidin-biotin (Vector Laboratories) amplification reaction.
The fluorescent specimens were imaged at 488 nm using helium-neon and argon ion lasers on a Zeiss LSM 10 confocal laser scanning microscope at the Optical Visualization Laboratory of the Beckman Institute for Advanced Science. Images were collected as optical sections through the entire thickness of each tissue section. The confocal laser scanning microscope was programmed to collect a set of images by optical scanning of planes at consecutive 1-2-,um depths through the 50-80-~.tmsection. In doing so, we were able to collect only the in-focus information resulting in a set of clear, high-resolution images. The individual images were then added together with perfect alignment to obtain a composite image. The composite image of the whole section was enhanced by Kalman filtration during data acquisition to improve depth of field. Confocal data sets were imported to an IBM 6000 workstation to perform adaptive histogram equalization and to render them as peak intensity projections.
RESULTS
Characterization of NOS activity in the SCN
The conversion of L-[ 3HI arginine to L-[3HI citrulline by SCN extract was linear within the first 10 mm (data not shown). Previous measurements in SCN reduced slices indicated that 2 mM L-NAME inhibited NOS activity completely (Ding et al., 1994 ). Here we use punches confined to SCN tissue to examine the NADPH and Ca2~/calmodulindependence of the reaction. Omitting Ca2~or NADPH from the reaction mixture abolished NOS activity. At 32~tM, trifluoperazine, a calmodulin antagonist, reduced the enzyme activity by half (Fig. IA) . The isoform was further characterized by measuring pH dependence of this activity. NOS activity in the SCN exhibited a pH optimum of 6.7 (Fig. 1B) .
We compared NOS activity among different brain regions. The specific activity of NOS in the SCN was 80% of that in the cerebellum and about threefold higher than in the hippocampus (Fig. IC) . No detectable difference in activity was measured among SCN samples collected in daytime (CT 7) and early (CT 14), and late night (CT 19) (Fig. 1D) .
Western blot analysis of NOS in the SCN
Western blots were performed to determine antigenic type, molecular weight, and relative levels of NOS protein expression in the SCN as compared with cerebellum (Fig. 2) . Immunoreactivity was observed in blots using anti-nNOS antibodies, which identified a band of 155 kDa. Antibodies against eNOS and iNOS did not reveal either isoform. Like the results from enzyme activity assays (Fig. 1C) , the amount of nNOS protein in the SCN was comparable to that in the cerebellum, and nNOS protein amounts were similar in SCN collected at CTs 7 and 14 ( Fig. 2A ; n = 4). To localize NOS within the cell, the western blot was performed on SCN tissue separated into membranebound and soluble fractions (Fig. 2B) . About half of NOS protein was associated with the membrane fraction in the SCN. Immunoreactivity at lower molecular weights increased in direct correlation with sample storage time (authors' unpublished data; Fig. 2A ).
Furthermore, there is a larger relative amount of this lower-molecular-weight species in fractionated samples that have spent 1-2 h at 4°Cbefore denaturing as compared with the whole samples that were immediately denatured on thawing (Fig. 2B ). This suggests that the lower-molecular-weight species may be proteolytic degradation products of nNOS. Blots of SCN and cerebellum probed with rabbit polyclonal antibody against the entire nNOS protein revealed one major band at 155 kDa, which specifically disappeared when primary antibody was preabsorbed with purified nNOS.
Immunocytochemical localization of nNOS in the SCN
The composite confocal micrographs revealed both neuronal somata and processes immunoreactive to nNOS in the SCN and surrounding regions of the hypothalamus (Fig. 3) . nNOS-positive neuronal somata in the SCN were sparse and mostly located in the ventrolateral region. Whereas few cell bodies were stained, nNOS-positive processes were intense and extensive, pervading the entire nucleus. Thus, they form a nitrergic plexus throughout the SCN. The nNOS-positive neurons within the SCN varied greatly in size, arborization, and intensity. nNOS-positive processes were more intense inside the SCN than in the surrounding hypothalamus, whereas the intensely stained neuronal somata appeared outside the SCN (Fig. 3A) . Preabsorption of the antibody with nNOS, the antigen used to raise the antibody, completely blocked nNOS immunoreactivity (Fig. 3B) . High-magnification confocal imaging of single optical sections in the ventrolateral SCN demonstrated both nNOS-positive somata and fibers with dense puncta (Fig. 3C) . In contrast to the SCN, confocal scans of the striatum exhibited much larger nNOS-positive somata without densely packed puncta (Fig. 3D) .
DISCUSSION
Functional studies have demonstrated a requirement for NO in resetting the biological clock (Ding et al., 1994; Weber et a!., 1995) , but the source of this diffusible messenger has been unclear. We report here that the rat SCN possesses substantial NOS that is attributable to nNOS based on molecular weight, Ca 2~/calmodulinrequirement, and pH dependence. Both nNOS activity and levels remain constant between day and night. Consistent with the high specific NOS activity, nNOS was found to be localized both ventrolaterally in sparse, weakly positive neuronal somata and in an intense plexus of processes that permeates the entire SCN.
Previously, NOS had been detected consistently in two hypothalamic areas: The supraoptic and paraventricular nuclei stain intensely both by histochemistry using NADPH-d activity of NOS and by ICC (Bredt et a!., 1991; Vincent and Kimura, 1992) . The SCN, however, had been refractive to staining by either method. Owing to the paucity of morphological evidence for NOS in the SCN, we measured and compared NOS specific activity in SCN tissue punches and other brain regions. Our results agree with previous observations that NOS activity measured from hippocampa! tissue is '-~25% of the cerebellar levels (Lin et al., 1994) . It was, however, surprising that the SCN exhibited a high level of NOS activity only 20% lower than that of the cerebellum, the brain region reported to have the highest NOS expression (Bredt et al., 1991) .
Our characterization of SCN NOS by examining Ca 2+ /calmodulin dependence suggests constitutive NOS expression in the SCN. To distinguish nNOS from eNOS, the enzyme activity was measured over a range of pH values. The highest activity was measured at pH 6.7, a value characteristic for nNOS (Hecker et a!., 1994b) and distinct from the pH 7.6 optimum of eNOS (Hecker et al., 1994a) . Western blot analysis of SCN samples with anti-nNOS antibody recognized a 155-kDa band present in nearly equivalent levels in both day and night. The quantitative similarity between nNOS levels in the SCN and cerebellum observed in specific activity measurements was confirmed by western blot. Thus, the aggregate data fully support nNOS as the prominent and abundant isoform expressed in the SCN in both day and night.
Several studies examining NOS expression in SCN from hamster and different rat strains report weak ICC or NADPH-d staining in ventrolateral perikarya (Decker and Reuss, 1994; Amir et al., 1995; Reuss et a!., 1995) . In contrast, the present study demonstrates nitrergic processes spread throughout the nucleus. In the Long-Evans rat, a relatively small number of cell bodies stained by anti-nNOS antibody were found in the retinorecipient ventrolateral region as well as borders of the core area of the SCN. Under confocal imaging analysis, however, an intensely staining profusion of fibers was evident, revealing a nitrergic plexus of collaterals and terminals. Staining of these fine structures was not evident under conventional microscopy; indeed, processes within the SCN have been reported to be of small caliber (van den Pol, 1980) . Localization of NOS in this plexus of fine fibers very likely accounts for the high NOS activity we have measured in the SCN. It is also possible that a portion of NOS in the SCN remains unstained owing to some unusual aspect of physical disposition such as interaction with anchoring molecules.
NOS-positive fibers and terminals have also been reported in other brain regions (Reuss et al., 1995) . Electron microscopic evaluation of monkey visual cortex identified 78% of nNOS immunoreactivity in axonal or dendritic profiles (Aoki et al., 1993) . Moreover, a recent study demonstrated that nNOS forms a complex through PDZ-containing protein domains with postsynaptic density-95 protein and NMDA receptors (Brenman et al., 1996) . This pattern suggests localization of functionally related elements near synaptic subcellular compartments. Also, we found~=50% of nNOS in the SCN and cerebellum was associated with the membrane portion. This is consistent with a recent detailed study in cerebellum (Hecker et al., I994b) .
Because nNOS in the SCN partitions with the membrane fraction, NO likely contributes to glutamatergic signal amplification and synchronization among the multiple cellular oscillators of the SCN.
Our findings that nNOS is largely localized to fibers and that the level and activity do not vary significantly between day and night contribute to an integrated assessment of nNOS function in the SCN. NOS is a necessary component of the signaling pathway by which light, glutamate, and NMDA receptor activation lead to resetting the clock phase (Ding et a!., 1994) . NO acts as a paracrine messenger in the SCN, as the extracellular NO scavanger, hemoglobin, blocks the effect of glutamate (Ding et al., 1994) . The activation of the few, weakly stained nNOS-positive cells in the ventrolateral SCN is unlikely to mediate such a global effect. The prevalence of nNOS in a fiber plexus throughout the SCN is compatible with the major signaling and synchronizing role of NO during nocturnal phase resetting by light/glutamate stimulation. It will be important to determine the sources of these NOScontaining fibers so that the role of NO in regulating circadian clock function can be further understood.
